Abstract
In patients with HCC listed for LT, the use of LRT is associated with a nonsignificant trend toward improved waitlist and posttransplant outcomes, though there is a high risk of selection bias in the available evidence. (Hepatology 2018;67:381-400).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have